- Home
- BRBR vs TNDM Comparison
BRBR vs TNDM Comparison
Compare BRBR & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BRBR | TNDM |
|---|---|---|
| Founded | 2019 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2019 | 2013 |
Fundamental Metrics
Financial Performance| Metric | BRBR | TNDM |
|---|---|---|
| Price | $13.84 | $15.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 19 |
| Target Price | ★ $36.63 | $28.00 |
| AVG Volume (30 Days) | ★ 6.8M | 2.1M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.65 | N/A |
| Revenue | ★ $2,316,600,000.00 | $1,014,736,000.00 |
| Revenue This Year | $6.28 | $8.11 |
| Revenue Next Year | $5.81 | $11.85 |
| P/E Ratio | $20.69 | ★ N/A |
| Revenue Growth | ★ 16.05 | 7.93 |
| 52 Week Low | $7.82 | $10.00 |
| 52 Week High | $59.10 | $29.65 |
Technical Indicators
Market Signals| Indicator | BRBR | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 72.60 | 47.14 |
| Support Level | $9.22 | $13.59 |
| Resistance Level | $18.96 | $16.00 |
| Average True Range (ATR) | 0.89 | 0.90 |
| MACD | 0.49 | 0.03 |
| Stochastic Oscillator | 93.90 | 51.92 |
Price Performance
Historical ComparisonAbout BRBR BellRing Brands Inc.
BellRing Brands Inc is a United States-based company engaged in providing nutrition-related products. Its brands, Premier Protein, Dymatize, and PowerBar provides various products including ready-to-drink protein shakes, powders and nutrition bars. The company's products are distributed through a diverse network of channel including club, food, drug and mass, eCommerce, convenience and specialty.
About TNDM Tandem Diabetes Care Inc.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.